Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (17 Alpha)-17-((1-oxoheptyl)oxy)-19-norpregn-4-en-20-yn-3-one
2. 19-norethindrone Enanthate
3. Norethindrone Enanthate
4. Norethisterone Oenanthate
1. 3836-23-5
2. Norethindrone Enanthate
3. Noristerat
4. Norethisterone Enantate
5. Norigest
6. Norethisterone Oenanthate
7. Norlutin Enanthate
8. [(8r,9s,10r,13s,14s,17r)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] Heptanoate
9. Sh 393
10. Hy3s2k0j0f
11. Nee
12. Chebi:34894
13. 17alpha-ethynyl-17beta-heptanoyloxy-4-estren-3-one
14. Nsc-22846
15. Norethisterone Enantate (norethindrone Enanthate)
16. Sovel
17. 19-norpregn-4-en-20-yn-3-one, 17-[(1-oxoheptyl)oxy]-, (17a)-
18. Unii-hy3s2k0j0f
19. Ccris 6526
20. 17alpha-ethynyl-19-nortestosterone Enanthate
21. Noristerat (tn)
22. Ncgc00182712-01
23. 17alpha-ethynyl-19-nortestosterone 17-heptanoate
24. Einecs 223-326-7
25. Lg 202
26. Brn 3176529
27. Norethindrone Heptanoate
28. Norethisterone-enanthate
29. 17alpha-ethinyl-19-nortestosterone Enanthate
30. 17-alpha-ethinyl-19-nortestosterone Enanthate
31. Dsstox_cid_28590
32. Dsstox_rid_82861
33. Dsstox_gsid_48664
34. Schembl354296
35. 17-alpha-ethynyl-17-beta-heptanoyloxy-4-estren-3-one
36. 17-beta-heptanoyloxy-17-alpha-ethynyl-4-oestren-3-one
37. 19-nor-17alpha-pregnen-20-ynone, 17beta-heptanoyloxy-
38. Chembl3187229
39. Dtxsid2048664
40. 3-oxo-19-nor-17alpha-pregn-4-en-20-in-17-yl-heptanot
41. Bcp10922
42. Hy-a0285
43. Nsc22846
44. Zinc4217172
45. Tox21_113027
46. 19-nor-17alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-, Heptanate
47. S6589
48. 19-norpregn-4-en-20-yn-3-one, 17-((1-oxoheptyl)oxy)-, (17alpha)-
49. Akos015896289
50. Ac-6835
51. Db14678
52. Norethisterone Enantate [mart.]
53. Zk-5410
54. Norethisterone Enantate [who-dd]
55. Norethisterone Enantate [who-ip]
56. As-13385
57. Cas-3836-23-5
58. Sh-8.0393
59. Cs-0019768
60. Norethisteroni Enantas [who-ip Latin]
61. 17.alpha.-ethinyl-19-nortestosterone Enanthate
62. 17.alpha.-ethynyl-19-nortestosterone Enanthate
63. D08285
64. 836n235
65. 17.alpha.-ethynyl-19-nortestosterone 17-heptanoate
66. Q7050956
67. Wln: L E5 B666 Ov Mutj E1 Fov6 F1uu1
68. 19-nor-17.alpha.-pregn-4-en-20-yn-3-one, Heptanate
69. 19-nor-17.alpha.-pregn-4-en-20-yn-3-one, Heptanoate
70. 17.alpha.-ethynyl-17.beta.-heptanoyloxy-4-estren-3-one
71. 19-nor-17-alpha-pregnen-20-ynone, 17-beta-heptanoyloxy-
72. 19-nor-17.alpha.-pregnen-20-ynone, 17.beta.-heptanoyloxy-
73. (17alpha)-17-((1-oxoheptyl)oxy)-19-norpregn-4-en-20-yn-3-one
74. 19-nor-17alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-, Heptanoate
75. 19-norpregn-4-en-20-yn-3-one, 17-((1-oxoheptyl)oxy)-, (17.alpha.)-
Molecular Weight | 410.6 g/mol |
---|---|
Molecular Formula | C27H38O3 |
XLogP3 | 6 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 8 |
Exact Mass | 410.28209507 g/mol |
Monoisotopic Mass | 410.28209507 g/mol |
Topological Polar Surface Area | 43.4 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 770 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Contraceptives, Oral, Synthetic
Oral contraceptives which owe their effectiveness to synthetic preparations. (See all compounds classified as Contraceptives, Oral, Synthetic.)
Contraceptive Agents, Female
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)
Contraceptive Agents, Hormonal
Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Norethindrone Enanthate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Norethindrone Enanthate, including repackagers and relabelers. The FDA regulates Norethindrone Enanthate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Norethindrone Enanthate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Norethindrone Enanthate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Norethindrone Enanthate supplier is an individual or a company that provides Norethindrone Enanthate active pharmaceutical ingredient (API) or Norethindrone Enanthate finished formulations upon request. The Norethindrone Enanthate suppliers may include Norethindrone Enanthate API manufacturers, exporters, distributors and traders.
click here to find a list of Norethindrone Enanthate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Norethindrone Enanthate DMF (Drug Master File) is a document detailing the whole manufacturing process of Norethindrone Enanthate active pharmaceutical ingredient (API) in detail. Different forms of Norethindrone Enanthate DMFs exist exist since differing nations have different regulations, such as Norethindrone Enanthate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Norethindrone Enanthate DMF submitted to regulatory agencies in the US is known as a USDMF. Norethindrone Enanthate USDMF includes data on Norethindrone Enanthate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Norethindrone Enanthate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Norethindrone Enanthate suppliers with USDMF on PharmaCompass.
A Norethindrone Enanthate written confirmation (Norethindrone Enanthate WC) is an official document issued by a regulatory agency to a Norethindrone Enanthate manufacturer, verifying that the manufacturing facility of a Norethindrone Enanthate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Norethindrone Enanthate APIs or Norethindrone Enanthate finished pharmaceutical products to another nation, regulatory agencies frequently require a Norethindrone Enanthate WC (written confirmation) as part of the regulatory process.
click here to find a list of Norethindrone Enanthate suppliers with Written Confirmation (WC) on PharmaCompass.
Norethindrone Enanthate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Norethindrone Enanthate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Norethindrone Enanthate GMP manufacturer or Norethindrone Enanthate GMP API supplier for your needs.
A Norethindrone Enanthate CoA (Certificate of Analysis) is a formal document that attests to Norethindrone Enanthate's compliance with Norethindrone Enanthate specifications and serves as a tool for batch-level quality control.
Norethindrone Enanthate CoA mostly includes findings from lab analyses of a specific batch. For each Norethindrone Enanthate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Norethindrone Enanthate may be tested according to a variety of international standards, such as European Pharmacopoeia (Norethindrone Enanthate EP), Norethindrone Enanthate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Norethindrone Enanthate USP).
LOOKING FOR A SUPPLIER?